There are a couple of new big events I’m really happy to announce that CB Insights will be hosting.
They have the same formula as our other events:
Phenomenal speakers & content
Amazing networking via 1:1 lounge and app
On June 11, we’re hosting The Future of Insurance conference. We’ve already got 2 public company insurance company CEOs joining us as speakers, and a host of great startup founders in insurtech (with many more to be announced).
If CPG incumbents were not already woke to the threats they face, this should serve as their “oh isht” reminder that “suddenly” has arrived.
A couple of notes:
Maintaining relevance will not come from cost cutting. Sorry private equity/activists.
I’m also sorry to report that starting a direct-to-consumer (D2C) offshoot for your existing brands is not going to miraculously save you. “Let’s be the Dollar Shave Club of kitchen cleaning supplies” is not the solution.
Building a skill for Alexa that allows people to buy your old-school, outdated brands is also hardly sufficient.
CPG firms are facing a multi-front war in which every part of their business is changing and needs to be defended, fortified, and reinvented.
Yup — everything:
The products they build
How they identify changing consumer tastes (traditional market research isn’t working)
How they market
The channels through which they distribute
The technologies that underpin their supply chain
The business models they’re using
The competitors they worry about (small brands and insurgent models are the ones to watch)
This requires fundamental changes to every aspect of your business.
Let’s hope folks in CPG wake up (for their own sake).
I’m excited to announce that we’re also going to be hosting The Future of Health in NYC on October 2-3, 2019.
We’ll be talking about health with leading VCs, healthcare giants, and unicorn startups, covering everything from disease prevention to smart foods to wearables to how AI is reinventing clinical trials.
And of course, we’ll be discussing the many moves of Apple, Google, Alibaba, Tencent, and others into healthcare.
We will also have a startup exhibitor hall for the first time, which we’re very excited to unveil.
Get your tickets here. Early bird rates expire February 28.
Don’t hate the player
Executives from seven major pharma companies, including Merck and Pfizer, were questioned about pricing practices in a Senate hearing today.
The execs cited the complicated pharma supply chain as a key reason for dramatic price increases.
We examine why the supply chain is opaque and inefficient, and what startups are doing to try to fix it. Check it out here.
I’m worth it
Lidar’s high costs have made it difficult to scale. But as startups are working to build the technology in a way that’s affordable and reliable enough for mass-market production, the space is becoming more competitive.